Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors

  • T-Cells were genetically modified in a lab to recognize specific proteins on brain tumor cells.
  • CAR-T cells were modified to reprogram suppressor T-cells into killer T-cells to fight the tumor.
  • The modifications made T-cells more effective in battling cancer by outsmarting its ability to hide from detection.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)